CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Salt Lake City, Utah, United States and 144 other locations
The purpose of this study is to learn about the safety and effects of updated COVID-19 vaccines (called BNT162b2) in participants 5-...
Phase 3
Salt Lake City, Utah, United States and 13 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
Clinton, Utah, United States of America and 262 other locations
The purpose of this study is to learn about the safety and effects of an updated COVID-19 vaccine (called BNT162b2) in adults 18 to-...
Phase 4
Salt Lake City, Utah, United States and 4 other locations
study treatment works in the study) of the study medicine (called nirmatrelvir/ritonavir) for potential treatment of coronavirus disease 2019 (COVID...
Phase 3
Salt Lake City, Utah, United States and 74 other locations
the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...
Phase 4
Salt Lake City, Utah, United States and 149 other locations
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...
Phase 2, Phase 3
West Jordan, Utah, United States and 91 other locations
This study will evaluate 2 dose levels of mRNA-1283 in participants ≥6 months to \<12 years to determine the optimal dose level per age group.
Phase 2
South Ogden, Utah, United States and 30 other locations
The purpose of this study is to investigate the safety, tolerability, and pharmacokinetics (PK) of single- and multiple-dose administration of S-8922...
Phase 1
Salt Lake City, Utah, United States and 2 other locations
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...
Phase 3
Salt Lake City, Utah, United States and 465 other locations
Clinical trials
Research sites
Resources
Legal